David Reynolds

David brings over 18 years of Neuroscience experience to SV as a Venture Partner in the Dementia Discovery Fund team.

David joined SV after serving as Chief Scientific Officer of Alzheimer’s Research UK for three years. ARUK is Europe’s largest dementia research charity investing in various forms of neurodegenerative research, both in academic labs and translational research including drug discovery.

Previously David has worked in the pharmaceutical industry for 18 years at Merck Sharp & Dohme, Lundbeck and latterly Pfizer, where he was the Cambridge Neuroscience & Pain research site head. He has held a variety of R&D leadership roles with responsibilities ranging from exploratory biology, through drug discovery, early clinical development and business development in multiple disease areas, but with a focus on neuroscience and pain.

Outside of SV, David enjoys playing hockey, keeping fit, gardening and keeping marine fish.

Academic Credentials
MA and PhD from the University of Cambridge, UK; Visiting Professor at the Institute of Neurology, University College London, UK